Prognosis
Trudeau Signs Deal to Make Novavax Covid-19 Vaccine in Canada
- U.S. biotech firm agrees to produce shots at Montreal facility
- PM under pressure to secure more doses amid supply crunch
This article is for subscribers only.
Prime Minister Justin Trudeau announced plans to manufacture Novavax Inc.’s Covid-19 vaccine in Canada, making it the first coronavirus shot that will be produced in the country.
Canada has signed a memorandum of understanding with Maryland-based Novavax “to pursue the production” of the vaccine at a facility being built in Montreal by the National Research Council, a government agency, according to a statement Tuesday from the Canadian leader. Vaccine production is set to begin in late July.